Related Experiment Video
Updated: Jun 6, 2025
09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
11.2K
Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology
Alejandro Serrano1,2, Sara Zalba1,2, Juan Jose Lasarte2,3
1Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
Pharmaceutics
|November 27, 2024
Summary
Regulatory T cells (Treg) in the tumor microenvironment hinder cancer immunotherapy. Computational models help identify Treg mechanisms for targeted therapies, improving treatment outcomes.
Area of Science:
- Immunology
- Computational Biology
- Cancer Research
Background:
- Tumor microenvironment (TME) complexity, particularly regulatory T cells (Treg), contributes to immunotherapy failure in cancer patients.
- Treg play a critical role in immune escape for tumors, posing a challenge for targeted therapies due to their systemic immune-regulatory functions.
Purpose of the Study:
- To review computational mathematical models simulating Treg roles in immunotherapy resistance.
- To identify key Treg molecules and mechanisms within the TME for targeted therapeutic strategies.
- To highlight emerging preclinical and clinical combination therapies targeting Treg.
Main Methods:
- Quantitative in silico approaches using mechanistic mathematical models.
- Integration of multi-scale information from immune cells, tumor cells, and therapy effects.
- Review of diverse computational models and experimental validation studies.
Main Results:
- Computational frameworks enable simulation of Treg-mediated immune resistance mechanisms.
- Identification of specific Treg-associated molecules crucial for TME immunosuppression.
- Overview of current trends in novel Treg-targeting therapies.
Conclusions:
- Mathematical models are valuable tools for understanding Treg's contribution to immunotherapy failure.
- Targeting specific Treg molecules and functions within the TME is a promising therapeutic avenue.
- Combination therapies targeting Treg show potential for enhancing cancer immunotherapy efficacy.
